How do we overcome treatment resistance in a sarcoma cancer with already limited treatment options? 25 Jul 2023 Leiomyosarcoma is a type of soft tissue sarcoma that is hard-to-treat and associated with a poor prognosis. Scientists at the ICR are working to better understand the biology of this cancer to develop more targeted and effective treatment options. Elena Daviter-Nowell spoke to Dr Will Kerrison about the future of cancer treatment for patients with leiomyosarcoma. Find out more Show/Hide
Olaparib – a story of hope for cancer patients 11 Apr 2023 In 1995 researchers at The Institute of Cancer Research, London, uncovered the breast cancer susceptibility gene BRCA2. This discovery helped families to assess their cancer risk through genetic testing, enabling them to be closely monitored or take preventative measures. Find out more Show/Hide
BBC Radio 5 Live Drive shares message of hope from ICR’s Centre for Cancer Drug Discovery 31 Jan 2023 The Institute of Cancer Research, London, hosted a special live broadcast of the BBC 5 Live Drive programme on Monday 30 January from the Centre for Cancer Drug Discovery – dedicated to celebrating advances in cancer research and promoting the new live episode of the 'You, Me & the Big C' podcast. Diana Cano, Laura-Maria Horga and Ichha Khanal attended the broadcast and share some highlights. Find out more Show/Hide
ASCO 2021: The science behind olaparib’s promise shown in the OlympiA early breast cancer trial 04 Jun 2021
Prostate Cancer Awareness Month 2020: Immunotherapy, state-of-the-art radiotherapy, olaparib and PSA screening 24 Mar 2020